At the intersection of ancient plant medicine and modern neuroscience, Barrow Neurological Institute in Phoenix has secured $5 million to ask a question that conventional medicine has long left unanswered: can a psychoactive compound help heal a wounded brain? With half of all traumatic brain injury patients still suffering six months after injury, the institute's forthcoming ibogaine trial represents not merely a new treatment avenue, but a philosophical reckoning with the limits of anatomy-focused medicine and the deeper mysteries of mind and recovery.
Barrow launches $5M ibogaine trial for traumatic brain injury recovery
Approximately 50% of traumatic brain injury patients experience incomplete recovery or lingering symptoms after six months, driving the need for new therapeutic interventions.